Deferred revenue, net of current portion

Name: BridgeBio Pharma Deferred revenue, net of current portion by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

BridgeBio Pharma·Products & Services·1 segment·Rolls up to Contract Liabilities

Breakdown

Segment	Q3 '25	Q4 '25	Q1 '26
Research and Development Services	$1.6M	$2.1M	$1.9M
Total	$13.13M	$13.08M	$11.78M

Segments

Research and Development ServicesView metric